why choose us

First received: June 13, 2024

Clinical Trial: ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Tumor

Study Type: INTERVENTIONAL


Official Title: ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer and Compared With 18F-FDG and 68Ga-FAPI

Brief Summary: The objective of the study is to construct a noninvasive approach 68Ga-THP-Trop2 VHH PET/CT to detect the Trop-2 expression of tumor lesions in patients with thyroid cancer and to identify patients benefiting from Trop-2 targeting antibody-drug conjugate treatment.

Read more